Managing People with Hypertension and Cardiovascular Disease during COVID-19: Considerations for Health Providers, 3 June 2020
Other Language Versions
Abstract
Primary care health centers and providers who care for individuals with hypertension and cardiovascular disease have an important role to play in ensuring continued access to care, reducing the risk of coronavirus infection, and appropriately managing people with these co-morbidities who acquire COVID-19. This guidance includes these considerations.
Subject
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
Interpretation of laboratory results for COVID-19 diagnosis, 6 May 2020
(Washington, D.C., PAHO, 2020-05-06)Etiological confirmation of COVID-19 virus (SARS-CoV-2) infection can only be made by laboratory tests. In general, the currently available assays for COVID-19 can be classified into two groups: • The first group (virological ... -
Access to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemic
(Washington, D.C., PAHO, 2020-07-13)Appropriate and adequate management of people with noncommunicable diseases (NCDs) includes access to essential NCD medicines. Disrupted access to chronic medication for hypertension, diabetes, heart disease, mental health ...
